HighTower Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
ACH
GKIM
HRCM
PIM
FGP
HighTower Advisors's TNDM Position: Q3 2025 in Review
HighTower Advisors sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 121,460 shares — an estimated $2.26M sold.
HighTower Advisors first reported a position in TNDM in Q1 2015 and held it in 16 quarters. The position peaked at $4.1M in Q1 2015. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.
- HighTower Advisors reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
- HighTower Advisors sold 121,460 Tandem Diabetes Care shares in Q3 2025, an estimated $2.26M.
- HighTower Advisors first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 16 quarters.
- HighTower Advisors's Tandem Diabetes Care position peaked at $4.1M in Q1 2015.
- 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.
Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.